Research in earlier phases or small trials include evaluation of GLP-1s for indications such as cystic fibrosis-related diabetes, polycystic ovarian syndrome (PCOS), chronic obstructive pulmonary disease (COPD), Prader-Willi syndrome (PWS), asthma, substance or alcohol use disorder, and as add-on to insulin for type 1 diabetes
Even if appetite is low, try a protein smoothie or small protein-rich snack in the morning
Our goal is to help you achieve lasting, sustainable weight loss and enhanced well-being
Startsev, V
Despite missing forecast in sales this quarter, tirzepatide is part of the glucagon-like peptide-1 (GLP-1) receptor agonist wave that is projected to pull in yearly sales of $150 billion by 2032
The problem, he said, is there arent criteria written by a government agency or a medical society to determine which providers are treating patients appropriately and which arent